TY  - BOOK
AU  - Dukes,M.N.G.
AU  - Braithwaite,John
AU  - Moloney,J.P.
TI  - Pharmaceuticals, corporate crime and public health
SN  - 9781783471096
AV  - HD9665.5 .D835 2014
U1  - 338.4/76151 23
PY  - 2014///]
CY  - Cheltenham, UK, Northampton, MA
PB  - Edward Elgar Publishing
KW  - Pharmaceutical industry
KW  - Corrupt practices
KW  - Corporations
KW  - Product counterfeiting
KW  - Drugs
KW  - Standards
KW  - Drug Industry
KW  - legislation & jurisprudence
KW  - Fraud
KW  - Crime
KW  - Scientific Misconduct
KW  - fast
KW  - Pharmazeutische Industrie
KW  - gnd
KW  - Korruption
KW  - Arzneimittel
KW  - Produktpiraterie
KW  - Wirtschaftskriminalität
KW  - Misdrijven
KW  - gtt
KW  - Farmaceutische industrie
KW  - Gezondheidszorg
KW  - Läkemedelsindustrin
KW  - etik och moral
KW  - sao
KW  - ekonomiska aspekter
N1  - Book; Includes bibliographical references and index; Creating a medicine : why, how and how not --; Safe, unsafe and improper manufacturing practices --; Aggressive or misleading promotion --; The dark art of manipulation : the industry and its puppets --; Corruption, counterfeiting and fraud --; Pricing, monopolies, abuses and the law --; A criminological perspective on a worsening crisis --; Positive regulation : the complementary role of supports and sanctions --; A responsive criminal law of pharmaceuticals --; Privatizing enforcement --; A new capitalism : a new drug diplomacy
N2  - "Offering a considered analysis of pharmaceutical rights and wrongs as they have developed over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health advocates." -- dust jacket; "The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities--research, manufacturing, information, distribution and pricing--as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies"--Publisher description
ER  -